Market Overview:
The global cardiac pacing market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of heart diseases, technological advancements in cardiac pacing devices, and rising geriatric population. Based on type, the global cardiac pacing market is segmented into temporary cardiac pacing, single-chamber cardiac pacing, dual-chamber cardiac pacing, single-chamber ICD (implantable cardioverter defibrillator), dual-chamber ICD and three chamber CRT-P (cardiac resynchronization therapy pacemaker). Temporary pacemakers are used for short term treatment such as during surgery or when a permanent pacemaker cannot be implanted immediately. Single chamber pacemakers are used for patients with only one functional ventricle and dual chamber pacemakers are used for patients with both atrial fibrillation and bradycardia. Single chamber ICDs are used for patients who have experienced a sudden heart attack (myocardial infarction) or those who have an irregular heartbeat (arrhythmia). Dual chamber ICDs also include devices that provide cardioversion shocks for restoring normal heart rhythm as well as antiarrythmic drugs therapies delivered via transvenous leads system inserted under the skin on your chest.
Product Definition:
A cardiac pacing system is a device used to maintain an appropriate heart rate in patients with an abnormally slow heart rate or in those who have had a heart attack.
Temporary Cardiac Pacing:
Temporary cardiac pacing (TCCP) is a technique that uses an external pacemaker to provide temporary support to the heart. The method is used in patients who have suffered a myocardial infarction or have undergone coronary artery bypass graft surgery and require immediate assistance for pumping function of the heart.
Single-Chamber Cardiac Pacing:
Single-chamber cardiac pacing refers to a type of cardiac pacemaker that is used for treating bradycardia and tachycardia. The single chamber of the device contains a coil that generates an electric current to pace the heart. This current is conducted by electrodes placed on the skin around the heart.
Application Insights:
Bradyarrhythmia is one of the most common cardiac arrhythmia which affects around 20% to 30% of patients suffering from atrial fibrillation. The other common types of arrhythmias include tachyarrhythmia and heart block. In a patient suffering from atrial fibrillation, the risk for developing bradyarrhythmia is significantly high as compared to healthy individuals as well as patients with normal hearts. Therefore, permanent pacemakers are used in such cases owing to higher accuracy and better treatment options available for this condition than for others.
The use of temporary cardiac pace has been increasing over recent years due largely to technological advancements that have made it relatively easier and less expensive than before in comparison with permanent pacemakers.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of well-established healthcare facilities, availability of advanced medical devices, and high adoption rate for new technologies in this region. Moreover, increasing number of FDA approvals for pacemakers and cardiac resynchronization therapy (CRT) devices is also expected to drive growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising geriatric population and improving economic conditions in emerging countries such as India & China & Japan etcetera – collectively called Asia Pacific Heart Network (APHRN). In addition, growing awareness about atrial fibrillation treatment options through various programs organized by governments as well as non-government organizations will boost demand further during the projected time frame.
Growth Factors:
- Increasing incidence of cardiovascular diseases (CVDs)
- Growing geriatric population
- Rising demand for minimally invasive procedures
- Technological advancements in cardiac pacing devices
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Cardiac Pacing Market Research Report
By Type
Temporary Cardiac Pacing, Single-Chamber Cardiac Pacing, Dual-Chamber Cardiac Pacing, Single-Chamber ICD, Dual-Chamber ICD, Three- Chamber CRT-P, Three- Chamber CRT-D
By Application
Bradycardia, Atrial fibrillation, Heart failure, Syncope
By Companies
Medtronic, St. Jude Medical, Boston Scientific, BIOTRONIK, Sorin Group, IMZ, Medico, CCC, Pacetronix, Cardioelectronica, Qinming Medical, Neuroiz
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Cardiac Pacing Market Report Segments:
The global Cardiac Pacing market is segmented on the basis of:
Types
Temporary Cardiac Pacing, Single-Chamber Cardiac Pacing, Dual-Chamber Cardiac Pacing, Single-Chamber ICD, Dual-Chamber ICD, Three- Chamber CRT-P, Three- Chamber CRT-D
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Bradycardia, Atrial fibrillation, Heart failure, Syncope
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- St. Jude Medical
- Boston Scientific
- BIOTRONIK
- Sorin Group
- IMZ
- Medico
- CCC
- Pacetronix
- Cardioelectronica
- Qinming Medical
- Neuroiz
Highlights of The Cardiac Pacing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Temporary Cardiac Pacing
- Single-Chamber Cardiac Pacing
- Dual-Chamber Cardiac Pacing
- Single-Chamber ICD
- Dual-Chamber ICD
- Three- Chamber CRT-P
- Three- Chamber CRT-D
- By Application:
- Bradycardia
- Atrial fibrillation
- Heart failure
- Syncope
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cardiac Pacing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cardiac pacing is a medical procedure that helps to maintain a regular heart rate. It is often used in people who have heart problems or who are at risk for developing them. Cardiac pacing can also be used to help control blood pressure and improve the quality of life for people with chronic illnesses such as diabetes.
Some of the major players in the cardiac pacing market are Medtronic, St. Jude Medical, Boston Scientific, BIOTRONIK, Sorin Group, IMZ, Medico, CCC, Pacetronix, Cardioelectronica, Qinming Medical, Neuroiz.
The cardiac pacing market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Cardiac Pacing Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Cardiac Pacing Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Cardiac Pacing Market - Supply Chain
4.5. Global Cardiac Pacing Market Forecast
4.5.1. Cardiac Pacing Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Cardiac Pacing Market Size (000 Units) and Y-o-Y Growth
4.5.3. Cardiac Pacing Market Absolute $ Opportunity
5. Global Cardiac Pacing Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Cardiac Pacing Market Size and Volume Forecast by Type
5.3.1. Temporary Cardiac Pacing
5.3.2. Single-Chamber Cardiac Pacing
5.3.3. Dual-Chamber Cardiac Pacing
5.3.4. Single-Chamber ICD
5.3.5. Dual-Chamber ICD
5.3.6. Three- Chamber CRT-P
5.3.7. Three- Chamber CRT-D
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Cardiac Pacing Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Cardiac Pacing Market Size and Volume Forecast by Application
6.3.1. Bradycardia
6.3.2. Atrial fibrillation
6.3.3. Heart failure
6.3.4. Syncope
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Cardiac Pacing Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Cardiac Pacing Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Cardiac Pacing Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Cardiac Pacing Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Cardiac Pacing Demand Share Forecast, 2019-2029
9. North America Cardiac Pacing Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Cardiac Pacing Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Cardiac Pacing Market Size and Volume Forecast by Application
9.4.1. Bradycardia
9.4.2. Atrial fibrillation
9.4.3. Heart failure
9.4.4. Syncope
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Cardiac Pacing Market Size and Volume Forecast by Type
9.7.1. Temporary Cardiac Pacing
9.7.2. Single-Chamber Cardiac Pacing
9.7.3. Dual-Chamber Cardiac Pacing
9.7.4. Single-Chamber ICD
9.7.5. Dual-Chamber ICD
9.7.6. Three- Chamber CRT-P
9.7.7. Three- Chamber CRT-D
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Cardiac Pacing Demand Share Forecast, 2019-2029
10. Latin America Cardiac Pacing Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Cardiac Pacing Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Cardiac Pacing Market Size and Volume Forecast by Application
10.4.1. Bradycardia
10.4.2. Atrial fibrillation
10.4.3. Heart failure
10.4.4. Syncope
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Cardiac Pacing Market Size and Volume Forecast by Type
10.7.1. Temporary Cardiac Pacing
10.7.2. Single-Chamber Cardiac Pacing
10.7.3. Dual-Chamber Cardiac Pacing
10.7.4. Single-Chamber ICD
10.7.5. Dual-Chamber ICD
10.7.6. Three- Chamber CRT-P
10.7.7. Three- Chamber CRT-D
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Cardiac Pacing Demand Share Forecast, 2019-2029
11. Europe Cardiac Pacing Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Cardiac Pacing Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Cardiac Pacing Market Size and Volume Forecast by Application
11.4.1. Bradycardia
11.4.2. Atrial fibrillation
11.4.3. Heart failure
11.4.4. Syncope
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Cardiac Pacing Market Size and Volume Forecast by Type
11.7.1. Temporary Cardiac Pacing
11.7.2. Single-Chamber Cardiac Pacing
11.7.3. Dual-Chamber Cardiac Pacing
11.7.4. Single-Chamber ICD
11.7.5. DualChamber ICD
11.7.6. Three- Chamber CRT-P
11.7.7. Three- Chamber CRT-D
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Cardiac Pacing Demand Share, 2019-2029
12. Asia Pacific Cardiac Pacing Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Cardiac Pacing Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Cardiac Pacing Market Size and Volume Forecast by Application
12.4.1. Bradycardia
12.4.2. Atrial fibrillation
12.4.3. Heart failure
12.4.4. Syncope
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Cardiac Pacing Market Size and Volume Forecast by Type
12.7.1. Temporary Cardiac Pacing
12.7.2. Single-Chamber Cardiac Pacing
12.7.3. Dual-Chamber Cardiac Pacing
12.7.4. Single-Chamber ICD
12.7.5. Dual-Chamber ICD
12.7.6. Three- Chamber CRT-P
12.7.7. Three- Chamber CRT-D
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Cardiac Pacing Demand Share, 2019-2029
13. Middle East & Africa Cardiac Pacing Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Cardiac Pacing Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Cardiac Pacing Market Size and Volume Forecast by Application
13.4.1. Bradycardia
13.4.2. Atrial fibrillation
13.4.3. Heart failure
13.4.4. Syncope
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Cardiac Pacing Market Size and Volume Forecast by Type
13.7.1. Temporary Cardiac Pacing
13.7.2. Single-Chamber Cardiac Pacing
13.7.3. Dual-Chamber Cardiac Pacing
13.7.4. Single-Chamber ICD
13.7.5. Dual-Chamber ICD
13.7.6. Three- Chamber CRT-P
13.7.7. Three- Chamber CRT-D
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Cardiac Pacing Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Cardiac Pacing Market: Market Share Analysis
14.2. Cardiac Pacing Distributors and Customers
14.3. Cardiac Pacing Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Medtronic
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. St. Jude Medical
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Boston Scientific
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. BIOTRONIK
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Sorin Group
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. IMZ
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Medico
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. CCC
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Pacetronix
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Cardioelectronica
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Qinming Medical
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Neuroiz
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
